The U.S. Food and Drug Administration's vaccine advisory panel on Thursday voted unanimously to recommend that the agency phase out original versions of COVID vaccines for use in the unvaccinated, in favor of updated bivalent ...
Jan 27, 2023
0
3
In a recent experiment published in JAMA, physician-researchers at Beth Israel Deaconess Medical Center (BIDMC) tested one well-known publicly available chatbot's ability to make accurate diagnoses in challenging medical ...
Jun 15, 2023
0
22
Findings from a multi-center, international clinical trial reported by a Cleveland Clinic physician show that semaglutide reduced cardiovascular events by 20% in adults with overweight or obesity and established cardiovascular ...
Nov 13, 2023
0
99
In a set of identical twins, investigators led by researchers at Massachusetts General Hospital (MGH) and Children's Hospital Philadelphia (CHOP) have identified a mitochondrial disease not previously reported.
Oct 14, 2022
0
43
A new personalized cancer treatment can radically improve the outlook for some patients with bile duct cancer, finds an international multicenter trial involving researchers at UCL and University College London Hospitals ...
Jan 18, 2023
0
42
An RSV vaccine developed by Pfizer provides safe and effective protection in both seniors and newborns, clinical trial results show.
Apr 6, 2023
0
5
A new drug called Baxdrostat has been shown to significantly reduce high blood pressure (hypertension) in patients who may not respond to current treatments for the condition, according to results from a phase II trial led ...
Nov 8, 2022
0
18
A new study of more than 10 million North Carolinians, published this week in the Journal of the American Medical Association (JAMA), highlights just how effective COVID-19 vaccines, boosters and prior infection can be, both ...
Sep 28, 2022
0
50
Children who were recently diagnosed with type 1 diabetes need less supplemental insulin to keep their blood sugar in a healthy range if they use the immunotherapy drug teplizumab, a new study reports.
Oct 18, 2023
0
55
In screening for prostate cancer, the risk of overdiagnosis can be halved, a University of Gothenburg study shows. With the proposed diagnostic pathway, considerably fewer harmless tumors are found. This solves a big problem ...
Dec 8, 2022
0
162
